MEDecision Announces Executive Promotion

WAYNE, PA--(Marketwire - Mar 13, 2012) - MEDecision Inc., the leading provider in collaborative health management solutions, today announced that Ken Young has been promoted to chief financial officer.

Young has served as vice president of finance for MEDecision since 2010. For many years prior to that, he served as MEDecision's lead external auditor, helping the company comply with accounting, financial and regulatory requirements. In his new role as the company's Chief Financial Officer, he will oversee financial and legal operations and corporate compliance.

"We are pleased to welcome Ken to MEDecision's executive team," said Deborah M. Gage, president and CEO, MEDecision. "Ken has proved to be a strong strategic advisor and intuitive leader, helping to improve financial discipline, drive accelerated growth and expand our technology reach."

Young is a results-oriented senior financial executive experienced in providing business planning and optimization and performance measurement to high-growth public, private, U.S. and multinational companies. Most recently, he was vice president of finance for MEDecision, where he enhanced the company's operating performance through process improvement, cost control and new business development. Prior to that, he served in leadership roles at Grant Thornton LLP, where he oversaw audit and business advisory services for public and private technology, manufacturing and service organizations and was involved in several merger and acquisition transactions. Young holds a BS of Accountancy from Villanova University.

About MEDecision
MEDecision's contribution to the healthcare industry is a powerful platform that delivers meaningful data to inform the most important healthcare transaction: patient care. We start with a philosophy that patients, providers and payers are all driving towards better health outcomes and that this common interest dictates the need for collaborative working environments.

Then, we apply 23 years of experience, $85+ million in research and development and the strongest clinical knowledge to deliver the MEDecision collaborative health management platform, which includes Nexalign®, a health decision support service that applies analytics to information gathered from multiple sources to foster better business and clinical decisions on a patient's behalf, Alineo®, a health management platform for delivering outcome-driven case, disease, utilization and behavioral health management, and InFrame®, a set of tools to facilitate the health and performance management processes for physicians and accountable care organizations.